High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Aehr Test Systems has surged over 400% this year on a dramatic business transformation, but with a price-to-sales ratio that would make most investors flinch and insiders quietly selling into the rally, the question now is whether the momentum has any room left to run.
Aehr Test Systems beat quarterly estimates and issued FY2027 revenue guidance of $130-$150 million, backed by a $100.6 million backlog and improved gross margins.
Aehr stock soars on blockbuster Q2 earnings and impressive future guidance. But Wall Street sees AEHR shares as overvalued at current levels.
Aehr Test Systems climbed by 21.91 percent on Wednesday to close at $87.79 apiece, after management projected a sharp acceleration in its full-year growth for fiscal 2027, underpinned by a record backlog and the continued strong demand for semiconductor testing solutions in AI infrastructure. In an earnings call on Tuesday, the company said that it […]
Aehr Test Systems (NASDAQ:AEHR) shares jumped 30% after the semiconductor test and burn-in equipment provider reported fiscal fourth-quarter results that exceeded Wall Street expectations and provided a stronger-than-anticipated revenue outlook for fiscal 2027. The company posted adjusted...
The semiconductor equipment maker topped quarterly estimates and forecast fiscal 2027 revenue far above Wall Street expectations.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.